Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Hypercholesterolemia and ANGPTL3[original query] |
---|
Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels. Human mutation 2012 Feb 33 (2): 448-55. Huijgen Roeland, Sjouke Barbara, Vis Kelly, de Randamie Janine S E, Defesche Joep C, Kastelein John J P, Hovingh G Kees, Fouchier Sigrid |
ANGPTL3 Mutations in Unrelated Chinese Han Patients with Familial Hypercholesterolemia. Current pharmaceutical design 2019 3 25 (2): 190-200. Yang Yunyun, Yang Song, Jiao Xiaolu, Li Juan, Zhu Miaomiao, Wang Luya, Qin Yanw |
Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity. Arteriosclerosis, thrombosis, and vascular biology 2019 10 39 (11): 2248-2260. Banerjee Poulabi, Chan Kuo-Chen, Tarabocchia Michel, Benito-Vicente Asier, Alves Ana C, Uribe Kepa B, Bourbon Mafalda, Skiba Paul J, Pordy Robert, Gipe Daniel A, Gaudet Daniel, Martin Ces |
Evinacumab for Homozygous Familial Hypercholesterolemia. The New England journal of medicine 2020 8 383 (8): 711-720. Raal Frederick J, Rosenson Robert S, Reeskamp Laurens F, Hovingh G Kees, Kastelein John J P, Rubba Paolo, Ali Shazia, Banerjee Poulabi, Chan Kuo-Chen, Gipe Daniel A, Khilla Nagwa, Pordy Robert, Weinreich David M, Yancopoulos George D, Zhang Yi, Gaudet Daniel, |
- Page last reviewed:Feb 1, 2024
- Content source: